Recent Transactions

23-Nov-20
$120 million
United Kingdom flag
Target: 

Greencore Group plc

flag not available
Acquiror: 
N/A

Advised Greencore Group plc, a leading UK manufacturer of convenience foods based in Ireland, on its £90mm non pre-emptive equity placing

10-Sep-20
$195 million
United Kingdom flag
Target: 

Saga plc

United Kingdom flag
Acquiror: 
Sir Roger De Haan

Advised Sir Roger De Haan on his cornerstone investment of £100mm in Saga, the UK provider of products and services exclusively for the over 50s, as part of its £150m equity raise

06-Apr-20
$352 million
United Kingdom flag
Target: 

WH Smith PLC

flag not available
Acquiror: 
N/A

Advised WH Smith PLC, one of the UK’s leading retailers, on its £166m non pre-emptive equity placing and new £120mm financing facility

27-Nov-19
$320 million
United States flag
Target: 

David’s Bridal Inc.

flag not available
Acquiror: 
N/A

Advised David’s Bridal, a leading bridal gown and special occasion dress retailer, on its out-of-court recapitalization

18-Nov-18
$876 million
United States flag
Target: 

David's Bridal

flag not available
Acquiror: 
N/A

Advised the Ad Hoc Group of the company's $481mm term loan with respect to the company's prepackaged Chapter 11 restructuring

23-May-18
$93 million
United Kingdom flag
Target: 

Dairy Crest Group PLC

flag not available

Advised Dairy Crest, a leading British dairy company, on a non-pre-emptive cash placing, raising proceeds of approximately £70 million

02-May-18
$3.7 billion
Canada flag
Target: 

Concordia International Corp.

flag not available

Advised an Ad Hoc Group of Cross-over Debtholders on Concordia International’s cross-border Canadian restructuring and recapitalization, including a US$586.5mm common equity private placement, the equitization of ~US$1.7bn of unsecured debt and the partial paydown and exchange of ~US$2.2bn of secured debt

31-Oct-17
$2.0 billion
South Africa, Switzerland flags
Target: 

Hirslanden Private Hospital Group

flag not available

Advised Hirslanden Private Hospital Group, Switzerland's largest private hospital group and a wholly-owned subsidiary of Mediclinic International Plc, on the refinancing of its CHF 2.0 billion senior secured bank debt

04-Oct-16
$223 million
U.S.A., U.K. flags
Target: 

US rights to Toprol-XL (AstraZeneca)

Canada flag
Acquiror: 
Aralez Pharmaceuticals Inc.

Advised Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company in connection with the financing of its acquisition of the US rights to cardiovascular drug Toprol-XL (metoprolol succinate) and its Authorized Generic from AstraZeneca.

27-Mar-15
$1.4 billion
United Kingdom flag
Target: 

AA plc

flag not available

Advised AA plc, the UK’s leading roadside assistance provider, on the refinancing of its high yield bond and PIK instrument

31-Jul-13
$NA
United Kingdom flag
Target: 

CPP Group plc

Advised on the comprehensive restructuring of its balance sheet, including sale of the US business, terming out the existing RCF and creation of additional liquidity by the long term deferral of business partner payments

18-Jun-12
$NA
United Kingdom flag
Target: 

Pension Trustees of Howden Joinery Group plc

Advised the Pension Trustees of Howden Joinery Group plc in negotiating a revised schedule of deficit reduction payments, and with regards to their security position relative to the Company’s lenders

04-May-12
$55 million
United Kingdom flag
Target: 

Armajaro Trading Limited

United States flag
Acquiror: 
International Finance Corporation

Advised Armajaro Trading Limited, a global soft commodity trading house and supply chain manager, on raising mezzanine capital from the International Finance Corporation, a unit of the World Bank

11-Feb-11
$986 million
United Kingdom flag
Target: 

Findel plc

Advised Findel plc, a UK listed multi-channel retailer, on the restructuring of its balance sheet comprising an equity capital raising and refinancing of its debt and pension obligations

28-Jun-10
$1.3 billion
U.K., Australia flags
Target: 

Guinness Peat Group plc

Advised GPG plc, a listed investment company, on potential restructuring alternatives

show all